ArticleJournal of ophthalmology2021
Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method.
Article in Journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06371079 (Safety and Suitability of Implantable Collamer Lens), which is not on this map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Safety and Suitability of Implantable Collamer Lens (ICL) Implantation for Correction of Refractive Errors Without the Use of Dispersive Ophthalmic Viscosurgical Devices (OVDs)
Who cites it
12 citing papers in PubMed, 16 citations in OpenAlex.
- Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial.Clinical ophthalmology (Auckland, N.Z.) · 2022Trial
- Comparison of the efficacy of the patented anterior chamber maintainer method and traditional method for implantable collamer lens implantation in myopic eyes: A clinical study.The Journal of international medical research · 2025Article
- Repositioning of the completely prolapsed lacrimal tube after bicanalicular intubation: a novel technique.International ophthalmology · 2025Article
- Real-world study of phakic refractive lens for correction of high myopia.Eye and vision (London, England) · 2025Article
- Subjective and objective changes in visual quality after implantable collamer lens implantation for myopia.Frontiers in medicine · 2025Review
- A case of delayed recurrent hyphema following Implantable Collamer Lens (ICL) surgery.American journal of ophthalmology case reports · 2024Article
- Clinical observations of EVO-ICL implantation with single incision without viscoelastic agent.BMC ophthalmology · 2024Article
- Granzyme B degrades extracellular matrix and promotes inflammation and choroidal neovascularization.Angiogenesis · 2024Article
- Implanting toric implantable collamer lens displays better astigmatism correction than implantable collamer lens combined with manually limbal relaxing incision.BMC ophthalmology · 2023Article
- Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation.International ophthalmology · 2022Review
- Clinical observations of EVO-ICL implantation and changes in corneal astigmatism using a modified technique.BMC ophthalmology · 2022Article
- Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method.Journal of ophthalmology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the clinical efficiency of a novel ophthalmic viscosurgical device-free (OVD-free) method for intraocular collamer lens (EVO-ICL) implantation in myopic eyes.
methodsIn this study, 40 patients underwent ICL implantation for both eyes: one eye underwent traditional ICL implantation, and the other eye underwent OVD-free (pure) ICL implantation. Preoperative and postoperative UDVA, BCVA, equivalent spherical degree (SE), IOP, visual quality index, subjective visual quality scale, corneal endothelial cell density (ECD), operation time, and complications were compared between and within the traditional and pure ICL implantation groups.
resultsIncreased IOP >22 mmHg 2 h after surgery was noted in 8 eyes (20%) in the traditional group, but not in the pure group (0%,
conclusionsThe pure ICL implantation method was associated with faster visual acuity recovery, shorter operation time, and more stable intraocular pressure. Pure ICL represents a safe and convenient method for ICL implantation compared with the traditional method, completely eliminating OVD-related complications without causing additional complications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.